Outcome

Longer hyperbaric oxygen therapy (HBO) sessions significantly improve functional recovery stem cell mobilization and brain tissue growth in rats after ischemic stroke. The study found that three-week HBO treatments reduced inflammation enhanced neurogenesis and increased the production of crucial neurotrophic factors such as BDNF and GDNF compared to shorter two-day treatments.

Introduction

This study explores the impact of hyperbaric oxygen (HBO) therapy on stroke recovery by investigating its effects on bone marrow stem cells (BMSCs) neurogenesis gliosis and inflammation. Rats that experienced transient middle cerebral artery occlusion (MCAO) were treated with HBO for either three weeks or two days. The findings reveal that a longer duration of HBO therapy resulted in better functional recovery evidenced by lower Modified Neurological Severity Scores (mNSS). The extended HBO treatment significantly enhanced the mobilization of BMSCs to the damaged brain areas stimulated the expression of neurotrophic factors and promoted neurogenesis and gliosis. Additionally prolonged HBO therapy was effective in reducing inflammation. These results suggest that longer and repetitive HBO treatments could provide substantial benefits in neuronal repair and overall recovery after ischemic stroke.

Results

The study explored the effects of hyperbaric oxygen (HBO) therapy on rats that had undergone a transient middle cerebral artery occlusion (MCAO) a model to simulate ischemic stroke. Rats were treated with HBO either for three weeks or two days. The results demonstrated that rats receiving the longer three-week course of HBO therapy showed significantly better functional recovery as evidenced by lower modified neurological severity scores (mNSS).

The longer HBO treatments effectively mobilized bone marrow stem cells (BMSCs) to the ischemic brain areas indicating that the duration of HBO therapy is key to enhancing the migration and homing of these cells. Importantly the study also found that a three-week HBO course stimulated the expression of neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF). These factors are crucial for neurogenesis (the growth of new nervous tissue) and gliosis (the process leading to the formation of a glial scar).

Additionally the study noted that longer HBO therapy significantly reduced inflammation which is beneficial for neuronal repair after ischemic stroke. These findings suggest that extending the duration of HBO therapy could be more effective in aiding recovery and repair in stroke patients.

In summary the study indicates that HBO therapy particularly when applied over a longer duration promotes better functional recovery stem cell mobilization neurogenesis and reduces inflammation in a rat model of ischemic stroke.

Conclusion

In conclusion this study highlights the significant benefits of hyperbaric oxygen (HBO) therapy in enhancing recovery after ischemic stroke. The findings underscore that longer courses of HBO therapy—notably a three-week regimen compared to a two-day treatment—are more effective in promoting functional recovery as evidenced by lower Modified Neurological Severity Scores (mNSS) in rats. Critical to this improvement is the enhanced mobilization of bone marrow stem cells (BMSCs) to the ischemic area indicating that the duration of HBO therapy is vital in supporting the homing and proliferation of these cells. Additionally extended HBO treatments stimulated the expression of neurotrophic factors such as BDNF and GDNF improving neurogenesis and gliosis while also reducing inflammation. These collective effects suggest that prolonged HBO therapy can play a vital role in neuronal repair offering a promising avenue for enhancing therapeutic outcomes in stroke patients. Therefore further research should consider the optimal duration of HBO therapy to maximize its neurogenic and neuroprotective benefits.